Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
37.5%
% of CANC's 48 holdings also in WDNA
21.2%
% of WDNA's 90 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.7% | 2.5% | 2.5% |
|
ELI LILLY & CO | 4.7% | 2.3% | 2.3% |
|
BRIDGEBIO PHARMA, INC. | 4.1% | 2.0% | 2.0% |
|
GILEAD SCIENCES INC | 1.9% | 1.4% | 1.4% |
 |
NOVARTIS AG | 3.1% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to WDNA
 |
ASTRAZENECA PLC | 5.9% |
|
EXELIXIS INC | 3.7% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 3.6% |
|
REVOLUTION MEDICINES, INC. | 3.6% |
|
MERCK & CO. INC. | 3.2% |
 |
GENMAB A/S SPONSORED ADR | 3.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.0% |
|
DAIICHI SANKYO CO LTD | 2.9% |
|
NUVALENT, INC. CLASS A | 2.8% |
|
BEIGENE LTD. SPONSORED ADR | 2.8% |
CANC Underweight Relative to WDNA
|
NATERA INC | -4.0% |
|
TWIST BIOSCIENCE CORP. | -3.8% |
|
NOVOZYMES A/S-B SHARES | -3.5% |
|
VERICEL CORPORATION | -2.8% |
|
VERACYTE INC | -2.5% |
|
GERON CORP | -2.1% |
|
UNITED THERAPEUTICS CORP | -1.8% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.6% |
|
SAREPTA THERAPEUTICS INC | -1.6% |
|
ALNYLAM PHARMACEUTICALS INC | -1.5% |